Biofabrication2026

Abstract submission page

Call for Abstracts

Biofabrication 2026 invites researchers, clinicians, and innovators from across the globe to submit abstracts presenting original research in all areas of biofabrication.

The 2026 edition of the conference is structured around a curated portfolio of nearly 40 thematic Symposia, spanning the full breadth of the field — from biomaterials and bioinks, advanced bioprinting technologies, and tissue-specific biofabrication, to vascularized systems, disease models, digital biofabrication, sustainability, and emerging applications beyond medicine.

We welcome contributions in all domains of biofabrication, including but not limited to:

  • Biomaterials, hydrogels, and bioinks

  • Bioprinting technologies and manufacturing strategies

  • Tissue engineering and regenerative medicine

  • Organ and disease models

  • Vascularization and microphysiological systems

  • Cryofabrication and low-temperature biofabrication strategies

  • Digital biofabrication, AI, and predictive design

  • Biofabrication for food, sustainability, and non-mammalian living systems

  • Translational and clinical biofabrication

  • Emerging concepts and interdisciplinary approaches

Symposium-Based Submission

All abstracts must be submitted to a specific Symposium. Authors are invited to carefully review the list of available Symposia and select the one that best aligns with the scientific focus of their work.

This symposium-based structure ensures:

  • Expert-led review by Symposium chairs

  • Thematic coherence within sessions

  • Meaningful scientific dialogue among related contributions

If a submission is deemed to align more closely with a different Symposium, the Scientific Committee may recommend reassignment in consultation with the Symposium chairs.

Presentation Formats

Authors may indicate their preference for:

  • Oral presentation

  • Poster presentation

  • Either format

Given the highly curated nature of the program, oral slots are limited. High-quality submissions that cannot be accommodated as oral presentations may be offered poster presentations within the same Symposium.

Abstract Guidelines

  • Maximum length: 350 words

  • Abstracts should clearly describe the scientific context, methodology, key findings, and relevance to biofabrication.

  • Abstract may contain one graphical element (a figure, a multi-panel figure, a scheme, a graphical abstract, or a table).

Biofabrication 2026 aims to showcase cutting-edge science while fostering cross-disciplinary exchange and international collaboration. We look forward to receiving your contributions and to welcoming you to Monterrey for an exciting and forward-looking edition of the Biofabrication Conference.

How to submit your abstract(s) to Biofabrication 2026 in two simple steps

Step 1. Review the list of Symposia (below) and select the one that best aligns with your research. Click the (+) sign to display information on each Symposium.
Step 2. Access the Oxford Abstracts submission platform using the green button at the bottom of this page. Follow the online instructions to complete the required submission fields.
Please note: if this is your first time using Oxford Abstracts, you will need to create an account before submitting your abstract.

Step 1. Select a Symposium

Please identify the Symposium best suited for your research work. Activate the Symposium button to see a brief description.

Track 1. Biomaterials, Hydrogels and Bioinks

• Adaptative Matrices: Engineering Next-Generation Hydrogels for Tissue and Disease Modeling
Chairs:
Prof. Andrea Cosola (Politecnico di Torino, Italy)
Prof. Desirée Baruffaldi (Politecnico di Torino, Italy)
  • Smart biomaterials for adaptive matrices
  • DNA-integrated hydrogels
  • 3D/4D bioprinting of dynamic scaffolds
  • Temporal control of hydrogel mechanical properties
  • In vitro models for disease and tissue regeneration
  • Spatial precision in mechanobiology
  • Design principles of hydrogels and bioinks for biofabrication
  • Structured property function relationships in bioinks
  • Rheological and printability requirements for advanced bioprinting
  • Bioactive, stimuli-responsive, and multifunctional hydrogels
  • Cell-material interactions and biological performance of bioinks
  • Standardization, characterization, and benchmarking of bioinks
  • Translational challenges: scalability, reproducibility, and regulatory aspects
  • Emerging trends in sustainable and smart bioink materials
Chairs:
Ali Ahmadi (École de Technologie Supérieure, Canada)
Ali Tamayol (University of Connecticut, USA)
Hossein Ravanbakhsh (University of Akron, USA)
Mohamadmahdi Samandari (Old Dominion University, USA)
  • Foam-based biofabrication materials
  • Granular and microgel scaffolds
  • Macroporous transport and oxygenation
  • Freeform and embedded bioprinting
  • Hybrid multiphase tissue constructs
Chair:
Francisco M. Fernandes (Sorbonne University, France)
  • Cryoprinting for tissue engineering, disease modelling and cell crypreservation
  • Ice templating, freeze casting and directional freezing of macroporous biomaterials
  • Vascularization of scaffolds via controlled porosity
  • New cryogenic technologies for biological systems banking
  • New cryopreservation technologies for tissue banking
  • Cryogels and Cryo(bio)inks
  • Ice nucleating proteins and antifreeze proteins in cryofabrication and cryobiology
  • Engineering the cell environment through controlled ice nucleation and growth
  • In situ analytical techniques for cell freezing investigation
Chair: Prof. Shabir Hassan (Department of Biological Sciences, Khalifa University, Abu Dhabi - United Arab Emirates)

Keynote speakers:
Prof. Joao Mano (University of Aveiro, Portugal)
Prof. Peter Corridon (Khalifa University, United Arab Emirates)
Prof. Shabir Hassan (Khalifa University, United Arab Emirates)
Prof. Ricardo Levato (Utrecht University, Clinical Sciences, Netherlands)
  • Fundamentals of dECM Sourcing and Decellularization: Optimizing protocols for diverse tissues (e.g., skin, adipose, placenta) to balance cell removal with ECM preservation.
  • Advanced Characterization of dECM Bioactivity: Moving beyond histology to quantify the retention of key matrisome components (collagens, GAGs, growth factors) and their biological impact.
  • Next-Generation dECM Bioinks: Strategies for formulating, functionalizing, and 3D bioprinting with dECM to create complex, biomimetic constructs.
  • Integration of Bioprinted dECM with Host Tissue: Exploring cellular recruitment, vascularization, and innervation in implanted dECM-based grafts.
  • dECM for Diabetic and Chronic Wound Healing: Engineering pro-regenerative microenvironments that modulate inflammation and kickstart healing in stalled wounds.
  • Immunomodulation by Decellularized Matrices: Understanding how dECM components instruct macrophage polarization and other immune cells to promote a regenerative rather than a fibrotic outcome.
  • From Bench to Bedside: Scaling up production, navigating regulatory pathways (FDA, EMA), and clinical translation of dECM-based wound care products.
  •  Hybrid and Smart dECM Constructs: Combining dECM with synthetic polymers, nanoparticles, or drug delivery systems to create enhanced, multi-functional wound dressings.
  • Natural-source bioinks: polysaccharides, proteins, and natural composites
  • Nanocellulose-enabled bioinks/hydrogels: rheology control, reinforcement, and biofunctionality
  • Chitosan/chitin-derived hydrogels and their printability–bioactivity trade-offs
  • Nature-inspired stabilization and crosslinking
  • Functional natural hydrogels: adhesive, self-healing, stimuli-responsive systems
  • Application snapshots: skin, cartilage, bone, soft tissues, organoids, and disease models using natural inks
Chair:
Khoon Lim (University of Sydney, Australia)

Keynote speakers: Prof. Jelena Rnjak-Kovacina (University of New South Wales, Australia)
Prof. Yu Shrike Zhang (Harvard Medical School, USA)
  • Cryotemplating as bioassembly tools
  • Cryobioprinting for regenerative medicine
  • Cryoprotectant in biofabrication
  • Crystallisation in freezing process
  • Ice templating as printing tool
  • Cryotemplating for sacrificial bioprinting

Track 2. Advanced Bioprinting Technologies and Manufacturing Strategies

• Frontiers in FRESH and Embedded 3D Bioprinting
Chairs:
Prof. Daniel Shiwarski, Ph.D. (School of Medicine and Swanson School of Engineering, University of Pittsburgh, USA)
  • Advances in FRESH and embedded bioprinting
  • Embedded bioprinting of ECM-based tissues
  • Support-bath material innovations
  • Hybrid embedded-volumetric fabrication
  • Biohybrid and neuromuscular constructs
  • High-fidelity collagen and soft tissue printing
  • Vascularized tissue fabrication
  • Translational pathways for embedded printing
  • Development of NAMs using embedded bioprinting”
Chairs:
Prof. Andrew Daly (University of Galway, Ireland)
Jason Burdick (University of Colorado Boulder, USA)

  • Embedded and FRESH bioprinting

  • Scaling organ biomanufacturing using embedded bioprinting

  • Vascular network bioprinting

  • Complex microphysiological systems biomanufacturing

  • Granular support hydrogel

Chairs:
Prof. Nasim Anabi (University of California Los Ángeles, USA)
Prof. Ali Tamayol (University of Connecticut, USA)

Keynote speakers:
Prof. Milica Radisic (University of Toronto, Canada)
Prof. Shulamit Levenberg (Technion Israel Institute of Technology, Israel)
  • 3D/4D bioprinting of vascularized tissue constructs
  • Engineering perfusable and hierarchical vascular networks
  • Bioink design for vascularization and endothelialization
  • In vitro vascularized tissue models
  • Dynamic and adaptive (4D) vascular remodeling
  • Multiscale vascular architectures
  • Functional evaluation of vascularized tissues
  • Translational and scalable biofabrication approaches
Chairs:
Prof. Dr. Andrés Díaz Lantada (Universidad Politécnica de Madrid & IMDEA Materials Institute, Spain)
Prof. Carmelo De Maria (University of Pisa, Italia)
  • Fundamentals of 4D printing in tissue engineering
  • Smart and stimulus-responsive materials
  • Time-dependent shape and property transformations
  • Design and programming of scaffold dynamics
  • Bioinspired and biomimetic scaffold architectures
  • Cell-material interactions in dynamic environments
  • Multi-material fabrication and biofabrication strategies
  • Translational and manufacturing challenges
  • Biofabrication and Bioprinting using more than one material
  • Biofabrication and Bioprinting cocultures: Fabricating constructs containing more than one cell type
  • Development of multimaterial bioprinters
  • Biofabrication of complex tissue constructs 
  • Compartmentalization and bioprinting
  • Chaotic bioprinting
Chairs:
Javier Vazquez Armendariz (The Ohio State University, USA)
  • Advances in hybridization of manufacturing techniques for scaffold production
  • AI/ML driven optimization in biofabrication processes
  • Multi-material, multi-scale scaffold fabrication workflows
  • Integration of hydrogel printing with solid-material fabrication methods
  • Volumetric and light-based printing modalities for hybrid scaffolds
  • 4D Printing for dynamic and stimuli-responsive tissue scaffolds
  • Material innovations for hybrid scaffold manufacturing
  • In vitro and in vivo validation of hybrid scaffolds
  • Cross-disciplinary collaboration to bridge manufacturing engineering and regenerative medicine.
Prof. Daniel Nieto García (Advanced Scientific Research Center - CICA; University of Coruña, Spain)
Keynote speaker: Prof. Daniel Nieto García (Advanced Scientific Research Center - CICA; University of Coruña, Spain)
  • Breakthrough fabrication capabilities: Light-based biomanufacturing, particularly holographic and volumetric bioprinting, enables rapid creation of complex 3D living structures with micrometer-scale precision in a single exposure.
  • Advantages over conventional printing: Structured light approaches overcome the speed and resolution limits of layer-by-layer bioprinting while allowing precise control over geometry, stiffness, and microenvironmental cues.
  • Optical principles and technologies: The workshop examines holographic projection, wavefront shaping, and volumetric photopolymerization as key tools for high-resolution biofabrication.
  • Biological impact: These techniques allow active control of cellular organization, differentiation, and mechanobiological responses by engineering biomimetic tissues with defined mechanical and topographical features.
  • Future directions and applications: By integrating optics, materials science, and cell mechanobiology, the workshop highlights emerging opportunities and challenges in tissue engineering, disease modeling, and regenerative medicine.
Chair: Prof. Elena Juan Pardo (The University of Western Australia)
  • Advances in MEW hardware, control systems, and real‑time process monitoring
  • High‑precision control of fibre diameter, patterning, and 3D architecture
  • Material innovations for MEW
  • Melt electrowritten scaffolds for soft and hard tissue engineering
  • Hybrid biofabrication approaches integrating MEW with hydrogels, bioprinting, or ECM‑mimetic materials
  • Cell-material interactions in MEW microarchitectures and their impact on tissue maturation

Track 3. Tissue-Specific and Organ-Oriented Biofabrication

• Biofabrication of Soft Tissues

  • Biofabrication of soft tissues such as skin, muscles, tendons, ligaments, fat, blood vessels, nerves, cartilage, fascia, glands, and lymphatic tissue

  • Advances in fabrication technologies

  • Vascularized soft tissue constructs

  • Hybrid biofabrication methods for soft tissue biomimicry

  • Cell-material interactions

  • Tissue-specific bioinks for various soft tissues

Chair:
Khoon Lim (University of Sydney, Australia)
  • 3D bioprinting for bone
  • 3D bioprinting for ligament
  • biofabrication for tendon
  • biofabrication for cartilage
  • biofabrication of tissue interfaces
  • bioreactors for tissue maturation
  • Biofabrication and characterization of large pieces of skeletal muscle
  • Biofabrication of contractile skeletal muscle
  • Mechanical or dynamical characterization of muscle construct
  • Novel techniques to engineer large pieces of muscle
  • Implantation of muscle tissue in animal models
Chairs:
Prof. Sahar Salehi-Müller (University of Hohenheim, Germany)
Dr. Gerardo Cedillo-Servin (Eindhoven University of Technology, Netherlands)

Keynote Speakers:
Dr. Miguel Dias Moisés
Dr. Marco Costantini (Institute of Physical Chemistry, Polish Academy of Sciences, Poland)
  • Engineered skeletal, cardiac, and smooth muscle tissues as active, work-producing materials for biohybrid systems, actuators, and soft robotics not just regenerative medicine
  • Challenges in scaling, manufacturing, and performance optimization that limit engineered muscle from moving beyond proof-of-concept
  • The field transition from proof-of-print to proof-of-performance in volumetric muscle models
  • Volumetric engineered muscle as a critical testbed for achieving durable, repeatable, and application-relevant function in vitro
  • Biofabrication strategies enabling volumetric muscle through architectural control and multi-material integration
  • Design principles to enhance force generation and transmission, including anisotropy, fascicle-like bundling, tendon-like anchors, graded stiffness, and reinforcement structures
  • Integration of conductive phases and mechanical interfaces to translate contractility into measurable work
  • Maturation and training protocols tailored to skeletal, cardiac, and smooth muscle, addressing long-term stability and spatiotemporal heterogeneity
  • Advanced conditioning approaches such as electrical and optogenetic stimulation, perfusion, co-culture systems, and training bioreactors
  • Measurement, benchmarking, and standardization of volumetric muscle performance, including force dynamics, electrophysiology, calcium handling, imaging, strain mapping, and high-content functional phenotyping
  •  Biofabrication technologies
  • Spheroids and organoids
  • In-vitro disease modelling
  • Regenerative medicine
  • In-vitro toxicology and drug testing
  • Assembloids and spheroid fusion
Chair:
Dr. Tess De Maeseneer (Tissue Engineering Services & Solutions (TESS))
Dr. Ronak Afshari (University of California, Los Angeles, USA)
  • Biological and structural organization of native tubular tissues
  • Cell integration strategies for tubular tissue fabrication
  • Flow dynamics and computational methods in tubular biofabricated systems
  • Biofabrication strategies for multilayered tubular tissues
  • Fiber-based approaches for hierarchical tubular architectures
  • Maturation and functional evaluation of engineered tubular tissues
  • Translational challenges and clinical potential of tubular biofabrication

 

Chair: Prof. Elena Juan Prado (The University of Western Australia)
Keynote speaker: Prof. Jelena Rnjak-Kovacina (University of Sydney)
  • Bioprinting technologies for cardiovascular tissues (including extrusion, volumetric, hybrid)
  • Microarchitected scaffolds for cardiovascular applications
  • Vascular network fabrication and perfusable microvasculature
  • Engineered myocardial tissues
  • Biofabricated heart valves 
  • Advanced biomaterials for cardiovascular applications, including hydrogels, haemostatic materials, and fibre‑reinforced composites
  • Bioreactor based maturation, including mechanical, perfusion, and electrical conditioning
  • Micro-physiological disease models for cardiac and vascular research
  • Translation pathways toward clinically viable cardiovascular constructs
Chair: Daniel Nieto García (Advanced Scientific Research Center - CICA; University of Coruña, Spain)
  • Biofabrication strategies for oral soft and hard tissue regeneration
  • Biological and mechanical challenges of the oral environment
  • Advanced biomaterials and bioinks for dental applications
  • In situ and minimally invasive biofabrication approaches
  • Translational barriers in regenerative dentistry
  • Bridging academic research and spin-out development in oral biofabrication

Track 4. Vascularization, Microphysiological Systems & Disease Models

• Bioprinting Vascularized Tissue Constructs
Chairs:
Prof. Shulamit Levenberg (Technion, Israel Institute of Technology)
Prof. Shira Landau (Technion, Israel Institute of Technology)

Keynote speakers:
Ricardo Levato (Utrecht University, The Netherlands)
Tal Dvir (University of Tel Aviv, Israel)

  • Multiscale vessels

  • Bioprinting hierarchical vascular networks with high precision

  • Bioprinting macrovessels

  • Bioprinting micovessels

  • The use of 4d bioprinting for vessel network formation and maturation

  • New bioprinting techniques for fabrication of vessel networks

  • Bioinks for vessel formation

Chairs:
Dr. Sushila Maharian, Ph.D. (Harvard Medical School, USA)
Prof. Yu Shrike Zhang (Harvard Medical School, USA)

Keynote speaker: Prof. Wilbur A. Lam, MD. Ph.D. (Emory University, School of Medicine, USA)
  • Organ-on-chip-based vascular models
  • Vascularized cancer models
  • Thrombosis-on-chip models
  • Diseased vascular models 
  • Biofabricated vascular models
  • Precision medicine
Chairs:
Prof. Gabriella C.J. Lindberg, PhD (University of Oregon, Knight Campus for Accelerating Scientific Impact, Bioengineering)
Prof. Luiz E. Bertassoni DDS, PhD (Knight Cancer Institute / Oregon Health Campus; Science University)
  • Bioprinting for spatial control of tumor, stromal, immune, and vascular compartments
  • Engineering tumor microenvironment complexity, including spatial, mechanical and biological cues
  • Integration of organoids and assembloids with biofabrication platforms to enhance cancer models
  • Organs-on-a-chip approaches for cancer modeling, including perfusion, immune recruitment, and dynamic signaling
  • Modeling tumor–host interfaces
  • Multi-scale cancer models, bridging single-cell resolution patterning with tissue- and organ-level 
  • Benchmarking engineered cancer models against patient data
  • Applications in drug discovery, therapeutic screening, and precision oncology
  • Standardization, validation, and translational readiness”
Chairs:
Prof. Yu Shrike Zhang (Harvard Medical School, USA)
  • Technologies for cell-dense biofabrication
  • Scaffold-free strategies for high-density tissue construction
  • Spheroid-based bioprinting and modular tissue assembly
  • Physically assisted assembly of cell-dense tissues
  • Cell-dense biofabrication for organoid, assembloid, and tissue models
  • Engineering native-like cell-cell interactions and tissue microenvironments
  • Modeling development, disease, and regeneration using cell-dense tissues
Chairs:
Prof. Luiz E. Bertassoni DDS, PhD (Knight Cancer Institute / Oregon Health Campus; Science University)
Prof. Gabriella C.J. Lindberg, PhD (University of Oregon, Knight Campus for Accelerating Scientific Impact, Bioengineering)
  • Biofabricated tissue models for predictive safety and efficacy testing of drugs regulatory-ready applications.
  • Microphysiological systems (MPS), organoids and tissue models, i.e. benchmarking and validating
  • Patient-specific models with demographic analysis
  • Diversity in cell sourcing: iPSC lines, primary cells, and patient-derived samples
  • Scaling of biofabricated models, e.g. 96-well plate platforms
  • Biofabrication workflows for reproducible and automated drug screening
  • Reduction of animal products in biofabrication workflows
  • Use of biofabricated tissue models for discovery of new therapeutic targets
  • Standardization and QC: from bioinks and materials to biological readouts
  • Integration of omics analyses

Track 5. Digital Fabrication & Artificial Inteligence

• Machine Learning and Digital Twins for Predictive Biofabrication
  • AI-enabled Process Intelligence: Development and application of ML models for analyzing/optimizing the materials and process of biofabrication.
  • Digital Twins for Predictive Biofabrication: The roles of digital twins in real-time monitoring and predictive analytics for biofabrication processes and biofabricated products.
  • Clinical Translation: Novel applications of ML and Digital Twins in biofabrication for tissue engineering, healthcare systems, regenerative medicine, and surgical planning.
  • Materials Optimization for Biofabrication: Using AI to optimize materials formulation for a target performance and functionality
  • Future Challenges: Challenges and future directions in integrating ML and digital twins into materials design and biofabrication workflows.
Chairs:
Andrew Daly (University of Galway, Ireland)
Prof. Rui M. A. Domingues (International Iberian Nanotechnology Laboratory, Portugal)
  • Bioink design and optimisation: Use of AI/ML  techniques to optimise and/or design new bioink formulations
  • Advancing software: Use of AI/ML to advance, streamline and develop biofabrication software.
  • Process optimisation: Using AI/ML to accelerate bioprinting parameter optimisation.
  • Robotics and automation: Integration of AI and robotics to improve automation in biofabrication processes.
  • Advancing quality control in biofabrication: Computer vision for real-time monitoring and quality control during Biofabrication.
  • Computational design and modelling: AI-assisted computational design of bioprinted constructs.
  • Image Analysis and Tissue Engineering: Use of AI-powered imaging or assessment techniques to monitor tissue quality and functionality post-bioprinting.
  • From 3D to 4D Biofabrication: Leveraging AI to simulate and design constructs that evolve in shape, mechanics, and biological function over time

Track 6. Community Building

• ISBF Early Career Researchers Symposium
Chairs:
Philipp Fisch (ETH Zürich, Department fo Health Sciences, Switzerland)
Hossein Ravanbakhsh (The University of Akron, USA)
  • Career development for early career researchers
  • Transition to independence as an early career PI
  • Starting and managing a research lab
  • Academic and industry career pathways
  • Publishing strategies and peer review processes
  • Grant writing and funding opportunities
  • Translating research to industry and startups
  • Challenges for start-ups in the Biofab arena
  • The balance between science and marketing
  • From the lab to the market: An exciting journal
  • Stories of success and crisis
  • Lessons learned in the process of searching for funding
  • Efforts to democratize access to biofabrication platforms 
  • Biofabrication in low-resource settings
  • Do-it-yourself biofabrication equipment
  • Education and outreach programs to widespread Biofabrication
  • Teaching Biofabrication: Examples, experiences in the classroom and lab
Chair: Prof. Koichi Nakayama, M.D., Ph.D. (Saga University School of Medicine, Japan)
  • Biofabrication-related Technology developed by/in Industry  
  • Scaling biofabrication technology of biofabrication products
  • New commercial  products, services, and technology for the biofabrication community
  • Industrial/commercial applications of biofabrication technologies
  • Bioprinting and biofabrication at scale
  • Teaching Biofabrication: Examples, experiences in the classroom and lab

Track 7. Biofabrication for Emerging Applications

• Biofabrication of Food
Chair:
Prof. Shulamit Levenberg (Technion Israel Institute of Technology, Israel)

Keynote speaker:
Prof. Yu Shrike Zhang (Harvard Medical School, USA)
  • Bioprinting Cultivated meat and fish
  • Cellular agriculture
  • Edible bioinks
  • Bioprinting alternative proteins
  • Bioprinting fat and fat alternatives
  • Biofabrication techniques in food production
  • Spatial organization of stem cells and biomaterials for building 3D hierarchical tissues
  • Bioprinting and biofabrication strategies for multi-scale tissue architecture
  • Regulation of stem cell states (proliferation, differentiation, migration) in 3D systems
  • Hydrogel design and cell–material interactions enabling tissue hierarchy
  • Challenges and opportunities in engineering functional stem cell–derived tissues
  • Biofabrication inside the human body
  • Minimally invasive approach for bioprinting
  • Miniaturized bioprinting tools and delivery systems
  • Bioink requirements for in situ and in vivo printing
  • Trajectory planning and printing on dynamic tissues
  • Real-time imaging and process feedback
  • In situ process monitoring and quality control
  • Translational and regulatory challenges
Chairs:
José Rubén Morones Ramírez (Universidad Autónoma de Nuevo León, México)
  • Synthetic living hybrid materials (SLMs and ELMs)
  • Genetic and metabolic programming of biofabricated constructs
  • Integration of engineered microbes within synthetic scaffolds
  • Cell-free synthetic biology embedded in fabricated materials
  • Spatial control of function across molecular, cellular, and macroscale levels
  • Biofabrication strategies for adaptive and responsive materials
  • Translational applications in health, environment, and biomanufacturing
  • Scale-up, robustness, and manufacturability of living biofabricated systems
  • Interfaces between biomaterials science and synthetic biology
  • Synthetic living hybrid materials (SLMs and ELMs)
  • Genetic and metabolic programming of biofabricated constructs
  • Integration of engineered microbes within synthetic scaffolds
  • Cell-free synthetic biology embedded in fabricated materials
  • Spatial control of function across molecular, cellular, and macroscale levels
  • Biofabrication strategies for adaptive and responsive materials
  • Translational applications in health, environment, and biomanufacturing
  • Scale-up, robustness, and manufacturability of living biofabricated systems
  • Interfaces between biomaterials science and synthetic biology
Chair:
Prof. Riccardo Levato (University Medical Center Utrecht, The Netherlands)
  • Biofabrication technologies to engraft bioactive elements (growth factors, drugs, small molecules, gene editing vectors, nano and microparticles)
  • Laser-powered triggered delivery of payloads
  • Gene editing strategies in biofabrication and bioprinting
  • Multi-modal constructs with patterned bioactive molecules and growth factors
  • Biofunctionalization
  • Controlled and programmable degradation and release of bioactive compounds
  • Spatiotemporal control and release to pattern cell responses and differentiation
  • Bioprinting of immunomodulatory, complex structures
  • Bioprinted materials for spatially controlled immunotherapy
  • Bioprinting of microneedle patches and therapeutic patches

Step 2. Submit your Abstract Using Oxford Abstracts

Enter here to Oxford Abstracts for Biofabrication 2026